Behrad Derakhshan insider trades: Edgewise Therapeutics (EWTX) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Behrad reports to the SEC
Open-market buys and sales
8 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 12, 2026 | EWTX | ↓ Sell | 5,100 | $43.81 | $223K | Direct | Aug 14, 2026 (2d) |
| Aug 12, 2025 | EWTX | ↓ Sell | 2,491 | $13.39 | $33K | Direct | Aug 14, 2025 (2d) |
| May 2, 2025 | EWTX | ↓ Sell | 1,691 | $16.45 | $28K | Direct | May 7, 2025 (5d) |
| Feb 5, 2025 | EWTX | ↓ Sell | 10,000 | $30.03 | $300K | Direct | Feb 7, 2025 (2d) |
| Sep 20, 2024 | EWTX | ↓ Sell | 42,068 | $29.03 | $1.2M | Direct | Sep 24, 2024 (4d) |
| May 2, 2024 | EWTX | ↓ Sell | 1,718 | $18.91 | $32K | Direct | May 3, 2024 (1d) |
| Feb 9, 2024 | EWTX | ↓ Sell | 10,000 | $20.03 | $200K | Direct | Feb 9, 2024 (0d) |
| May 2, 2023 | EWTX | ↓ Sell | 1,747 | $8.90 | $16K | Direct | May 3, 2023 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other EWTX insiders
Open-market trades in the last 12 months
About Behrad Derakhshan's insider trades
Behrad Derakhshan is Chief Business Officer at Edgewise Therapeutics (EWTX). Since May 2, 2023, Behrad has reported no open-market purchases and 8 sales worth $2.1M on SEC Form 4. In the last 12 months: 1 sale ($223K).
Their filings also include option exercises (8 filings), grants and awards (8 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every EWTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.